Joe Ninosky is an experienced professional in the life sciences industry with over 20 years of expertise in drug substance process development and analytical method development. Currently the Owner and Founder of Symbiotx, Ninosky provides critical CMC insights for pharmaceutical product development. Previous roles include Vice President of CMC at Biotheryx, Inc. and Revelation Biosciences Inc., and Senior Director of Chemical Engineering at TriLink BioTechnologies, where significant contributions included the successful scale-up of processes related to COVID-19 vaccine production. Ninosky holds a Master’s degree in Chemical Engineering and several certifications in Six Sigma and project management, reflecting a strong commitment to leadership, innovation, and process optimization in biopharmaceutical development.
This person is not in any teams
Symbiotx
Expert pharmaceutical consulting per all things CMC: process development, analytical method development, scale-up, tech transfer, GMP manufacturing of clinical and commercial drug substances and drug products. Hands-on, passionate, mission-oriented. If you need help making your drug a reality, we can help.